arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

AEMETIS, INC

AMTX
$1.77 ▼ -0.12 (-6.60%) at close
Materials ·Industrial Organic Chemicals ·USIndustrial Organic Chemicals
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
53
Health
Fair
Neutral
auto_awesome

Analytical Summary

AEMETIS, INC demonstrates solid fundamentals with strength in Return on Common Equity (%). Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $106.2M
Dividend Yield —
Revenue Growth -26.2% ↘
Op. Margin -18.8% ↘
ROIC 12.3% ↘
FCF / Share $-0.38 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -0.33
info Valuation on last close. End-of-day price, Sep 24, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$197.63M
↓ -26.2% —
Net Income Profit after all expenses
$-77.00M
↑ +12.0% —
Operating Margin Operating profit as % of sales
-18.8%
↓ -24.7% 10th
FCF / Share Free cash flow per share
$-0.38
↑ +67.3% —
Long-Term Debt Long-term obligations
$63.90M
↓ -74.2% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
9
Returns ↓
90
Financial Health ↑
73
Cash Quality ↓
32

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 17 years · 64 quarters